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Summary
 
The acquired immune responses are crucial to the survival of 
 
Yersinia
 
-infected animals.
 
 
 
Mice
lacking T cells are sensitive to 
 
Yersinia
 
 infection, and a humoral response to 
 
Yersinia
 
 can be pro-
tective. Diverse mechanisms for 
 
Yersinia 
 
to impair and evade the host innate immune defense
have been suggested, but the effects of 
 
Yersinia
 
 on lymphocytes are not known. Here, we demon-
strate that after a transient exposure to 
 
Y
 
.
 
 pseudotuberculosis
 
, T and B cells are impaired in their
ability to be activated through their antigen receptors. T cells are inhibited in their ability to
produce cytokines, and B cells are unable to upregulate surface expression of the costimulatory
molecule, B7.2, in response to antigenic stimulation. The block of lymphocyte activation results
from the inhibition of early phosphorylation events of the antigen receptor signaling complex.
Through the use of 
 
Y
 
.
 
 pseudotuberculosis
 
 mutants, we show that the inhibitory effect in both T cells
and B cells is dependent on the production of 
 
Yersinia
 
 outermembrane protein (Yop) H, a tyro-
sine phosphatase. Our results suggest a mechanism by which the pathogenic bacteria may mod-
ulate a wide range of T and B cell–mediated immune responses.
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A
 
n animal host must possess a well-developed adaptive
immune response as well as robust innate immunity
to clear most microbial pathogens. Pathogenic bacteria em-
ploy diverse mechanisms to avoid the innate immune defense
system (1, 2). Several bacterial pathogens reprogram the
course of endosomal development to prevent fusion with
lysosomal elements, creating a privileged niche within host
cells. Many bacteria produce surface components to resist
phagocytosis and complement killing, while others possess
enzymes that inactivate components of the host defense sys-
tem. Known mechanisms by which bacteria affect the adap-
tive immune response are sparse. 
 
Mycobacterium tuberculosis
 
 has
been reported to inhibit antigen presentation by macro-
phages through an unknown mechanism (3). Clearly, the
adaptive immune response remains essential for host defense
of bacterial pathogens, including the pathogenic members
of the genus 
 
Yersinia 
 
(4, 5).
The genus 
 
Yersinia
 
 includes the causative agent of bubonic
plague, 
 
Y
 
.
 
 pestis
 
, as well as the common enteric pathogens,
 
Y
 
.
 
 enterocolitica
 
 and 
 
Y
 
.
 
 pseudotuberculosis
 
. Infection with 
 
Y
 
.
 
pseudotuberculosis
 
 and 
 
Y
 
.
 
 enterocolitica
 
 generally causes gastro-
enteritis and lymphadenitis. However, in some susceptible
individuals, infection is associated with the development of
reactive arthritis (6, 7). All three 
 
Yersinia 
 
species have a tro-
pism for lymphatic tissue. In animal model systems, 
 
Y
 
.
 
 pseudo-
tuberculosis
 
 and 
 
Y
 
.
 
 enterocolitica 
 
reach the intestinal tract, enter
through the M cells of the Peyer’s patches, and encounter
the host cellular elements (8). Several days after infection,
 
Yersinia
 
 are found in the mesenteric lymph nodes and, sub-
sequently, in the spleen and liver. Unlike most bacterial
enteropathogens that breach the epithelial barrier, such as
 
Shigella
 
 and 
 
Salmonella
 
 species, 
 
Yersinia
 
 are not found intra–
cellularly but, rather, are seen firmly fixed to the host cell
surface (9).
An essential key to 
 
Yersinia
 
’s pathogenicity is the pres-
ence of a 70-kb plasmid (pYV) (10, 11). This plasmid, found
in all three pathogenic 
 
Yersinia 
 
species, encodes a type III
secretion system and several temperature- and calcium-reg-
ulated virulence proteins or effector molecules, the 
 
Yersinia
 
outermembrane proteins (Yops).
 
1
 
 
 
Yersinia
 
 also express sev-
eral adhesion molecules that allow the bacteria to preferen-
tially attach to different classes of integrin receptors on the
surface of epithelial, fibroblast, macrophage, and lympho-
cyte cell lines. Direct cell contact, in combination with the
type III secretion machinery, allows 
 
Yersinia
 
 to translocate
the Yops from the cytoplasm of the bacteria directly into
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 BCR, B cell antigen receptor; FA, focal
adhesion; HEL, hen egg lysozyme; MCC, moth cytochrome c; MOI,
multiplicity of infection; Yop, 
 
Yersinia
 
 outermembrane protein. 
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the cytoplasm of a host cell to modify host cell function(s).
At least six virulence proteins are thought to be active in the
host cell: YopH, YopE, YopJ/P, YopO, YopM, and YopT.
The effects of these Yops have been studied primarily in
macrophages and epithelial cell lines (10, 11). YopH, a tyro-
sine phosphatase, was reported to dephosphorylate p130
 
cas
 
,
p125
 
FAK
 
, and paxillin, all tyrosine-phosphorylated proteins
found in the focal adhesion (FA) complexes. YopH activity
was found to cause the disassembly of FA, which impairs
the entry of the bacteria into HeLa cells or their phagocyto-
sis by macrophages (12–14). Additionally, YopH may func-
tion cooperatively with YopE in inhibiting phagocytosis by
neutrophils (15). YopE activity is associated with depoly-
merization of the host cell cytoskeleton, thus preventing in-
gestion of the bacteria (16). YopJ/P, in certain conditions, in-
duces apoptosis in macrophages in vitro and in vivo (17–19).
In other conditions, YopJ/P can affect nuclear factor 
 
k
 
B–
mediated signal transduction in macrophages through an
unknown mechanism and, subsequently, inhibit TNF-
 
a
 
 pro-
duction (20–22). Although the functions of YopO, which has
homology to serine/threonine kinases (23), and YopT are
not clear, it has been shown that both YopO and YopT can
perturb the cytoskeleton of epithelial cells in the absence of
YopE (24, 25). YopM has homology to von Willebrand fac-
tor, suggesting that it may play a role in plasma clotting (26,
27). Thus, 
 
Yersinia
 
 produce a spectrum of virulence factors
which when injected into host cells may alter host cell an-
tiphagocytic function and, sometimes, host cell viability.
Although these observations suggest possible mechanisms
for 
 
Yersinia
 
 to impair the host innate immune system, the
effect of 
 
Yersinia
 
 on components of the adaptive immune
system is not clear. This is despite the fact that acquired im-
mune responses are crucial to the survival of infected animals
and the observed link between 
 
Yersinia
 
 infection and autoim-
munity. During the natural course of 
 
Yersinia
 
 infection, the
bacteria almost certainly encounter lymphocytes as they col-
onize and multiply extracellularly in Peyer’s patches, mesen-
teric lymph nodes, spleen, and liver (5, 8). Indeed, T cells as
well as macrophages are present in 
 
Yersinia
 
-induced lesions in
the spleen and liver (28). In vitro studies indicate that 
 
Yer-
sinia
 
 can bind both T and B lymphocytes, presumably via the
integrins on the lymphocytes (29, 30). Thus, T and B lym-
phocytes are potential targets for the bacteria in vivo.
In this study, we found that 
 
Y
 
.
 
 pseudotuberculosis
 
 can directly
interfere with T and B cell antigen receptor–mediated acti-
vation and that the lymphocyte inhibitory effects are depen-
dent on the production of YopH, the tyrosine phosphatase.
The presence of YopH in T and B cells results in hypo-
phosphorylation of almost all tyrosine-phosphorylated
components associated with the antigen receptor signaling
complex after receptor activation. Consequently, T cells,
transiently exposed to 
 
Yersinia
 
, were unable to flux calcium
and produce cytokines. Likewise, primary B cells, tran-
siently exposed to 
 
Y
 
.
 
 pseudotuberculosis
 
, were unable to up-
regulate the costimulatory molecule, B7.2, in response to
antigen stimulation. As a result, a wide range of T and B
cell–mediated immune responses may be profoundly af-
fected during infection. These observations suggest a novel
 
way by which 
 
Yersinia
 
 can incapacitate the host adaptive
immune response. Thus, 
 
Yersinia
 
 seems to have evolved to
produce effectors that are specifically designed for the dif-
ferent cell types that the bacteria encounter in the course of
an infection.
 
Materials and Methods
 
Cell Lines, Y. pseudotuberculosis Strains, and Growth Conditions.
 
5C.C7 T cell lines derived from 5C.C7 TCR transgenic mice
(specific for moth cytochrome c [MCC]/I-E
 
k
 
; reference 31) were
maintained in RPMI supplemented with 
 
l
 
-glutamine, nonessential
amino acids, sodium pyruvate, penicillin/streptomycin, and 10%
fetal bovine serum. T cell lines were stimulated every 2 wk with
irradiated splenocytes and MCC peptide (88–103). 2 d after the ad-
dition of peptide and splenocytes, the medium was supplemented
with 5 U/ml of IL-2. Jurkat T cells, MCC9 T cell hybridoma
(specific for MCC/I-E
 
k
 
 [32]), and CH27 were grown in the RPMI
medium using 10% bovine calf serum. Primary B cell cultures were
maintained in RPMI supplemented with 3% fetal bovine serum.
Wild-type and mutant 
 
Y
 
.
 
 pseudotuberculosis
 
 (33) were initially
grown overnight to plateau phase in 2
 
3
 
 YT at 26
 
8
 
C. Cells were
diluted 1:50 into 2
 
3
 
 YT supplemented with 20 mM sodium oxa-
late and 20 mM magnesium chloride and grown for 2 h at 26
 
8
 
C,
then shifted to 37
 
8
 
C for 2 h. Bacterial numbers were determined
by OD
 
600
 
 
 
5 
 
1 
 
3
 
 10
 
9
 
 bacteria/ml.
 
Lymphocyte Infection and Activation.
 
MCC9 T cells, extensively
washed with antibiotic-free medium, were exposed to the speci-
fied 
 
Y
 
.
 
 pseudotuberculosis
 
 strain at a multiplicity of infection (MOI)
of 10 for 1 h at 37
 
8
 
C. Gentamicin (final concentration 100 
 
m
 
g/ml)
was added to kill the bacteria followed by T cell activation assays.
T cells in 96-well plates were activated by either MCC peptide
(88–103) complexed with glycosyl phosphatidylinositol–linked I-E
 
k
 
(34), 1 
 
3
 
 10
 
5
 
 CH27 cells and MCC peptide, or 1 
 
m
 
M ionomycin
and 25 ng/ml PMA in 200 
 
m
 
l of supplemented RPMI medium.
After overnight incubation at 37
 
8
 
C, 100 
 
m
 
l of medium was assayed
for IL-2 production by standard sandwich ELISA (JES6-1A12,
JES6-5H4; PharMingen) and streptavidin-europium detection
(Wallac). For calcium flux, experiments were carried out by ex-
posing 5C.C7 T cells to 
 
Y
 
.
 
 pseudotuberculosis
 
 at an MOI of 50 for
1 h. Cells were loaded with the calcium-sensitive dye, Fura-2
(Molecular Probes), washed, and stimulated by an MCC peptide–
loaded, confluent layer of I-E
 
k
 
–expressing Chinese hamster ovary
cells, and monitored as described previously (35).
Jurkat T cells were exposed to specified 
 
Y
 
.
 
 pseudotuberculosis
 
 for
1 h at an MOI of 50 at 37
 
8
 
C, followed by the addition of anti-CD3
(OKT3 ascites, 1:100). After 5 min, cells were spun down at 4
 
8
 
C
and lysed with cytoplasmic extract buffer (1% NP-40, 150 mM
NaCl, 10 mM Tris [pH 8.0], 2 mM sodium orthovanadate, 10 mM
sodium fluoride, 5 mM 
 
b
 
-glycerol phosphate, 5 mM dinitrophe-
nyl phosphate, 100 
 
m
 
g/ml leupeptin, 100 
 
m
 
g/ml pepstatin, and
1 
 
mM PMSF). Nuclei were removed by centrifugation at 48C. The
cytoplasmic extract (1 3 106 cell equivalents) was diluted into 23
reducing Laemmli buffer and run on 10% SDS-PAGE. Phospho-
tyrosine proteins were detected by Western blotting, using the
unconjugated antiphosphotyrosine antibody, 4G10 (Upstate Bio-
technology), followed by an anti–mouse Ig–horseradish peroxi-
dase conjugate (P0260; Dako) for detection. Blots were devel-
oped with enhanced chemiluminescence (Amersham Pharmacia
Biotech). Each blot was subsequently stripped and reprobed
for b-actin. CD3z immunoprecipitations were conducted as
described (36).1345 Yao et al.
B cells were isolated from MD4 anti–hen egg lysozyme (HEL)
Ig transgenic mouse spleens by negative depletions with anti-Thy1,
anti-CD4, anti-CD8, and anti–Mac-1 (Caltag) as described (37).
Cells were .98% B2201 as assessed by FACS®. Anti-HEL B cells
were exposed to wild-type or mutant Y. pseudotuberculosis at an
MOI of 50 for 1 h at 378C, followed by the addition of HEL
protein (500 ng/ml). After 3, 10, and 30 min, the B cells were lysed
with cytoplasmic extract buffer, nuclei were removed by centrifu-
gation, and 1 3 106 cell equivalents were diluted into 23 reducing
Laemmli buffer and run on 10% SDS-PAGE. Phosphotyrosine
proteins were detected by Western blot as described above.
For B7.2 upregulation, freshly isolated anti-HEL Ig B cells were
first incubated at 378C with the specified Y. pseudotuberculosis at an
MOI of 20. After 1 h, gentamicin was added to a final concentra-
tion of 100 mg/ml. Splenic B cells from anti-HEL Ig transgenic
or C57BL/6 mice were stimulated with HEL (500 ng/ml) or
anti-IgM (3 mg/ml; Jackson ImmunoResearch Laboratories), re-
spectively, for 12 h at 378C. B cells were then stained for FACS®
analysis using anti-B220–FITC (RA3-6B2; PharMingen) and anti-
B7.2–PE (GL1; PharMingen). Propidium iodide was included to
assess cell viability.
Results
Wild-type Y. pseudotuberculosis Inhibits Antigen-specific T Cell
Activation in a YopH-dependent Manner. The development of
a specific immune response is essential to resolve Yersinio-
sis. Since T cells are integral components of the specific im-
mune response, we investigated whether Yersinia infection
could significantly alter T cell activity by monitoring their
cytokine production in response to antigenic activation. In
the initial experiment, we preexposed either the APC, CH27,
an I-Ek–expressing B cell lymphoma, or MCC9, an MCC/
I-Ek specific T cell hybridoma, to either wild-type Yersinia
or a Yersinia lcr mutant. The lcr mutant possesses the virulence
plasmid, pYV, but is unable to produce or secrete Yops due
to a mutation in a Yop regulatory locus (38, 39). After a 1-h
incubation with Yersinia at an MOI of 10, the cells were
treated with gentamicin (to kill the bacteria) and then mixed
with MCC peptide and the appropriate untreated cells to
achieve antigen activation. As shown in Fig. 1, in both cases,
IL-2 production was significantly decreased after exposure
to wild-type Yersinia but not to the lcr Yersinia mutant. This
indicates that one or more secreted Yop(s) was responsible
for the observed cytokine inhibition. Interestingly, the Yer-
sinia inhibitory effect on cytokine production is much more
pronounced when T cells were preexposed to Yersinia, sug-
gesting that Yersinia’s effect is greater on T cells than on
CH27 cells. However, to definitively test if the bacteria were
directly affecting T cells, we needed to exclude the possi-
bility that, when the two cell types are mixed together, the
bacteria interact with the other cell type before gentamicin
killing takes effect. Therefore, plate-bound I-Ek/MCC pep-
tide (88–103) protein complex, instead of CH27 cells, was
used in subsequent T cell activation assays. MCC9 T cells
exposed to wild-type, but not a virulence plasmid–deficient
(pYV2) or an lcr mutant (data not shown) Yersinia, showed
a dramatic reduction in IL-2 production compared with
unexposed controls (Fig. 1 C). These data suggest that one
or more components of the Y. pseudotuberculosis virulence
plasmid can directly inhibit T cell activation.
To determine which Yop(s) are necessary for the sup-
pression of IL-2 production, several Yersinia Yop mutants
Figure 1. Y. pseudotuberculosis suppresses T cell antigen–specific IL-2
production in a YopH-dependent manner. IL-2 production of T cell ac-
tivation assays with (A) MCC9 or (B) CH27 preexposed to either wild-
type (Wt), YopH mutant (H2), Lcr mutant (Lcr2) Yersinia, or medium
alone (T); or with (C) MCC9 T cells activated by plate-bound MCC/I-Ek
after the T cells were preexposed to wild-type (Wt), YopH mutant (H2),
YopE mutant (E2), YopO/YopJ mutant (A2), pYV2 (P2) Yersinia, or
medium alone (T). At least three independent experiments were con-
ducted, and representative result is shown.1346 Suppression of Lymphocyte Activation by YopH
were screened in the T cell activation assay (Fig. 1 C). YopO/
YopJ- and YopE-deficient bacteria, but not YopH-defi-
cient bacteria, were able to inhibit IL-2 production as effi-
ciently as wild-type bacteria. In addition, the YopH mutant
was unable to inhibit IL-2 production when MCC9 was
stimulated by APCs (Fig. 1, A and B). These results suggest
that YopH is necessary for the inhibition of cytokine pro-
duction in T cells. Similarly, exposure to wild-type, but not
pYV-cured or YopH-deficient mutant, Yersinia inhibited the
MCC/I-Ek–specific production of IL-3, IL-4, and IFN-g
by T cell lines derived from the 5C.C7 TCR transgenic mice
(data not shown). Cell viability, as assayed by propidium
iodide staining and trypan blue exclusion, did not signifi-
cantly change as a result of exposure to Yersinia in any of the
above experiments (data not shown). These data suggest that
YopH may target a common component in cytokine acti-
vation pathways.
The YopH Inhibitory Effect Is Upstream of Calcium Flux and
Protein Kinase C Activation. YopH has tyrosine phosphatase
activity, and T cell activation through the antigen receptor
is known to require the rapid phosphorylation of the tyro-
sine kinases, CD3z chain, and linker/adaptor molecules
(40). The phosphorylation and clustering of these mole-
cules are critical to T cell activation, and these events precede
the activation of protein kinase C as well as the rapid changes
in intracellular calcium concentration accompanying T cell
activation. Protein kinase C activation and the intracellular
calcium flux are, in turn, required for induction of cyto-
kine production. As shown in Fig. 2, the YopH inhibitory
effect can be reversed by the addition of PMA/ionomycin,
indicating that the YopH-mediated cytokine suppression
was upstream of protein kinase C activation and calcium flux.
Consistent with this supposition, the ability of Yersinia-
exposed 5C.C7 T cells to flux calcium in response to anti-
gen was impaired in a YopH-dependent manner (data not
shown). These results suggest that the effect of YopH is
largely limited to early tyrosine phosphorylation events in
T cell signaling.
YopH Inhibits the T Cell Tyrosine Phosphorylation Signal
Cascade. The biochemistry of antigen receptor signaling
has been well characterized in the human T cell Jurkat line
(for a review, see reference 40). Hence, we evaluated whether
the induction of the tyrosine phosphorylation cascade in
response to TCR cross-linking by the mAb OKT3 is altered
when Jurkat cells are exposed to Yersinia. As shown in Fig. 3,
many tyrosine-phosphorylated proteins induced after TCR
cross-linking, including CD3z, were severely reduced or
absent in T cells exposed to wild-type or YopE-deficient,
but not pYV2 or YopH-deficient, mutant Yersinia compared
with the sham-exposed T cells. These results suggest that
YopH targets some of the earliest initiators of the T cell
signaling complex.
YopH Inhibits B Cell Antigen–specific Responses. The an-
tigen receptor on B lymphocytes (BCR) consists of the
membrane-bound Ig and associated Iga and Igb molecules.
Tyrosine phosphorylation of Iga and Igb is required for the
initiation of the tyrosine phosphorylation signaling cascade
after antigen binding (41). Because of the signaling similar-
ities between T cells and B cells, we tested whether the ini-
tial signaling events after BCR stimulation are affected by
exposure to Y. pseudotuberculosis. As in T cells, we found
that exposure to wild-type Yersinia interfered with the in-
duction of the early tyrosine phosphorylation signaling cas-
cade in response to antigen receptor engagement in a YopH-
dependent manner (Fig. 4). Anti-HEL Ig transgenic B cells
Figure 2. The inhibitory effect on T cell activation can be overridden
by PMA and ionomycin. IL-2 production from MCC9 T cells exposed to
wild-type (Wt), pYV2 (P2), or YopH2 (H2) Yersinia, or medium alone
(T) for 1 h and incubated overnight with PMA and ionomycin (PMA/
Iono) or 60 mg/ml of plate-bound MCC/I-Ek.
Figure 3. YopH inhibits tyrosine phosphorylation of the TCR signal-
ing complex. (A) Antiphosphotyrosine blot of resting (2) and OKT3-
activated (1) T cell lysates from Jurkat T cells exposed to either wild-type
(Wt), YopE2 (DE), YopH2 (DH), or pYV2 (P2) Y. pseudotuberculosis.
Arrows indicate the heavy and light chains of OKT3. (B) Blots were
stripped and reprobed for actin. (C) Antiphosphotyrosine blot of immu-
noprecipitated CD3z from extracts.1347 Yao et al.
were exposed to wild-type, pYV2, or YopH-deficient Yer-
sinia and activated with HEL. B cells exposed to wild-type
but not pYV2 or YopH-deficient Yersinia showed a drastic
reduction in the surface expression of B7.2 (Fig. 5) and CD69
(data not shown). Similarly, the induction of B7.2 and CD69
on splenic B cells isolated from C57BL/6 mice in response
to anti-IgM cross-linking was also impaired when the B cells
were exposed to wild-type but not pYV2 or YopH-defi-
cient Yersinia (data not shown). This effect was not due to
Yersinia-induced cell death since the number of live cells, as
assessed by propidium iodide, was not significantly different
among samples (data not shown).
Discussion
In this study, we have examined the interaction between
Yersinia and the adaptive immune system by monitoring the
response of T and B lymphocytes to antigen after a brief
exposure to Yersinia. Our results provide evidence that the
Y. pseudotuberculosis tyrosine phosphatase, YopH, inhibits the
signaling cascades associated with T and B cell antigen re-
ceptor activation. This is one of the first examples of a bac-
terial pathogen directly manipulating lymphocyte signaling
and activation. Continuation of this inhibitory effect may
explain why Yersinia infection, in some cases, is character-
ized by a chronic infection of lymphatic organs.
The consequences of the YopH dephosphorylation activ-
ity may affect a wide range of T and B cell–mediated im-
mune responses, including cytokine production. In fact, Yer-
sinia infection dramatically suppresses the induction of IFN-g
and TNF-a production in some mouse strains (42, 43). When
these cytokines are replaced exogenously, the mice are bet-
ter able to survive infection. Since infection with an lcr2 Yer-
sinia triggers IFN-g and TNF-a production in infected mice,
one or more Yops are likely responsible for the suppression of
cytokines. Recent experiments suggest that YopJ/P suppresses
TNF-a production in macrophages (20–22), whereas we
found that IFN-g production was reduced in T cells infected
with Yersinia. Thus, the inhibition in cytokine production ob-
served after infection with wild-type Yersinia may be due to the
combined action of YopH and YopJ/P on different cell types.
The pathological significance of our finding is not limited
to a bacteria-induced suppression of cytokine production.
The development of a T cell–mediated autoimmune disease,
reactive arthritis, has long been associated with Y. pseudotuber-
culosis and Y. enterocolitica infection in genetically susceptible
individuals. Inappropriate T cell signaling has been postulated
as a factor in the development of autoimmune diseases. Thus,
T cells exposed even briefly to wild-type Y. pseudotuberculosis
may signal aberrantly, if at all, for a significant period of time.
If a stimulus is delivered to the TCR during a partially re-
sponsive period, the T cell may respond inappropriately, lead-
ing to the development of abnormal immune responses. In
addition, complete T cell activation requires a signal delivered
through TCR–peptide/MHC complex and the engagement
of costimulatory molecules such as CD28/B7.2. A failure to
induce normal levels of B7.2 on APCs has been associated
with the induction of T cell nonresponsiveness (44). Al-
though many other factors are likely to be involved in the
development of reactive arthritis, we believe that the ability
of  Yersinia to disrupt TCR and BCR signaling cascades
may contribute to this condition in some individuals.
What Proteins Are Target(s) of YopH in T and B Cells? It
Figure 4. Yersinia inhibits tyrosine phosphorylation of the BCR signal-
ing complex in a YopH-dependent manner. (A) Antiphosphotyrosine blot
of cell extracts from splenic B cells from anti-HEL transgenic mice. B cells
were incubated with medium alone (B), wild-type (Wt), YopH2 (DH), or
pYV2 (P2) Yersinia for 1 h, then activated with HEL protein (500 ng/ml)
for the indicated times. (B) Blots were stripped and reprobed for actin.
Figure 5. YopH suppresses B cells anti-
gen–specific B7.2 upregulation. Splenic B
cells from anti-HEL Ig transgenic mice were
exposed to either wild-type (A), pYV2 (B),
or YopH2 (C) Y. pseudotuberculosis before
the addition of HEL protein. After 12 h, cells
were stained with FITC-conjugated anti-
B220, PE-conjugated B7.2, or propidium
iodide, and analyzed by FACS®. Only
B2201 and propidium iodide–negative cells
(live) were included in the analysis. Bold
lines represent expression of B7.2 on Yer-
sinia-exposed, HEL-activated cells. Thin
lines represent B7.2 expression on unex-
posed, HEL-activated B cells. At least three
independent experiments were conducted,
and a representative plot is shown.1348 Suppression of Lymphocyte Activation by YopH
has been suggested that the catalytic domain of YopH at the
COOH-terminal end of the molecule selectively targets
tyrosine-phosphorylated sites that contain the D/EpYxxP
motif (45). In addition, a domain in the NH2-terminal re-
gion of YopH may be required for the efficient recognition
of substrates. This substrate-binding domain exhibits a ligand
specificity that is similar to that of the Crk Src homology 2
domain (13). Although the target(s) of YopH in lympho-
cytes is not known, we observed that most of the tyrosine
kinases and adapter/linker proteins that are normally phos-
phorylated after T and B cell antigen receptor stimulation
were either not phosphorylated or rapidly dephosphorylated
in the presence of YopH. The three known YopH targets
identified in epithelial and Hela cells, paxillin, p125FAK, and
p130cas (12–14), and its closely related homologue, p105casL,
are also found in lymphocytes (46). Further, p105casL, asso-
ciated with the cell membrane and clustered integrins, is
known to be phosphorylated after TCR ligation (47). Thus,
as p105casL may be involved in both TCR and integrin sig-
naling, it is tempting to speculate that, in addition to the
CD3z-ZAP70 in T cells or the Iga/Igb pathway in B cells,
a second pathway involving paxillin-p125FAK-p105casL con-
tributes to lymphocyte activation. An abrogation of p105casL
phosphorylation may have a significant inhibitory effect on
T cell function. Alternatively, YopH may also target one
member or members of the known T cell signaling cascade,
including protein tyrosine kinases such as ZAP70 and Syk
and tyrosine-phosphorylated adapter/linker proteins such
as linker for activation of T cells (LAT), B cell linker pro-
tein (BLNK), and SH2 domain–containing leukocyte protein
of 76 kD (SLP-76), which all contain sequences similar to the
optimum YopH target consensus sequence. It is possible that a
rapid dephosphorylation of these proteins may destabilize the
TCR complex, which may lead to its disassembly and expo-
sure of most or all components of the TCR complex, includ-
ing CD3z, to phosphatases. We are currently characterizing
the cellular distribution and protein targets of YopH in lym-
phocytes to distinguish among these possibilities.
What Cells Are Targets of Yops during Infection? The Yops
play a crucial role in Yersinia virulence. Most past experi-
ments have focused on the effects of these Yops in epithe-
lial cells and macrophages. Yet, our work clearly demon-
strates the rapid and essential role of YopH in inhibiting T
cell and B cell signaling. Importantly, the redistribution and
reorientation of the cytoskeleton are necessary early events
for lymphocyte activation (48). Yet, both YopE and YopO,
which have been shown to disrupt actin filaments leading
to alterations in the cytoskeleton of both phagocytes and
epithelial cells (16, 49), have no demonstrable effect in our
assays. Furthermore, although YopJ/YopP induces apopto-
sis in macrophages (17, 19), neither primary B cells, T cell
lines, or T cell hybridomas appear susceptible to this viru-
lence factor. YopH activity has been shown to mediate
several effects in epithelial cells as well as macrophages, in-
cluding: inhibition of Fc receptor–mediated oxidative burst
in macrophages (50), inhibition of neutrophil functions
(51, 52), FA disassembly in epithelium cells, and inhibition
of phagocytosis in conjunction with YopE. These effects are
all very different from the one we report here. Thus, it ap-
pears that different Yops target different host cell types in-
volved in defense against Yersinia infection. By the same to-
ken, the enteropathogenic Yersinia harbor several different
adhesion molecules that mediate their attachment to host
cells. There is experimental evidence to suggest that some of
the adhesins are better adapted to deliver specific Yops to
certain host cells types. Invasin, which targets b1 integrins
(53, 54), is essential for Peyer’s patch translocation across the
epithelial barrier, but not as efficient for delivering Yops to
macrophages. Perhaps the plasmid-mediated adhesin, YadA,
suffices in delivering Yops into macrophages. Taken to-
gether, it appears that Yersinia have evolved to produce effec-
tors that are specifically designed for the different cell types
that the bacteria encounter in the course of an infection.
The study of pathogen–host interactions provides a fasci-
nating insight into the strategies used by microbes to ma-
nipulate normal host functions to their own benefit. The Yops
are part of a complex secretion–translocation apparatus that
responds to host cell cues and results in the delivery of an
array of proteins into the host cell cytoplasm. Homologues
of the secretory arm of this complex, the type III secretion
system, have been found in a growing number of patho-
genic gram-negative microorganisms. It is likely that other
pathogenic microorganisms secrete molecules analogous to
Yops to alter host cell function and cause immune suppres-
sion or an alteration in the immune response to the benefit
of the microbe. It is instructive to see, for example, that
Salmonella species have two fully functional type III secre-
tory systems, one involved in entry and the other involved
in intracellular replication, that are essential for virulence.
Moreover, one of these Salmonella type III secretory path-
ways delivers an effector protein, SptP/SptA, into the host
cell cytoplasm. SptP/SptA has a COOH-terminal phospha-
tase domain similar to that found in YopH and an NH2-
terminal domain that is homologous to the YopE cytotoxin
(55, 56). Curiously, infection with Salmonella can also trig-
ger reactive arthritis in humans. Similarly, Shigella and Chlamy-
dia and other pathogens have chromosomal islands contain-
ing type III secretory and effector homologues, and these
bacteria are likewise associated with the development of
autoimmune disease subsequent to infection. Is this the re-
sult of an underlying common strategy employed by many
bacteria to alter the host immune response? Regardless,
studying the molecular mechanisms of bacterial infection
and host immune responses will reveal additional subtleties
of bacterial pathogenicity and provide new information
about the development of immune response.
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